[^1]
| YWHAG Protein |
|---|
| Protein Name | 14-3-3 Gamma |
| Gene | YWHAG |
| UniProt ID | P61981 |
| PDB ID | 1a4p, 1g9n, 2b05 |
| Molecular Weight | ~28 kDa (247 aa) |
| Subcellular Localization | Cytoplasm, Nucleus, Membranes |
| Protein Family | 14-3-3 family (signaling adaptor/scaffold) |
| Expression | High in brain, especially [hippocampus](/brain-regions/hippocampus); ubiquitous |
The YWHAG gene encodes 14-3-3 gamma, a member of the highly conserved 14-3-3 protein family that functions as a critical scaffold and phospho-serine/threonine-binding protein in cellular signaling networks. The 14-3-3 proteins are essential for integrating multiple cellular processes including signal transduction, cell cycle regulation, apoptosis, metabolism, and stress responses 1. In the nervous system, 14-3-3 gamma is particularly important for neuronal function, synaptic plasticity, and protection against neurodegenerative processes 2.
14-3-3 gamma shares the characteristic architecture of the 14-3-3 family:
- Nine α-helices forming a horseshoe-shaped dimer
- Phosphopeptide-binding groove recognizing phosphorylated serine/threonine residues in client proteins
- Conserved binding motifs: RSXpSXP and pTXY (phospho-Ser/Thr-Xaa-Any-Tyr)
- Dimeric structure allows simultaneous binding of two client proteins, enabling scaffold function
The dimer creates a functional platform ~56 kDa in size, capable of bringing together different signaling components 3.
YWHAG is one of seven mammalian 14-3-3 isoforms (β, ε, η, γ, θ, ζ/δ, σ). While sharing structural homology, each isoform has distinct expression patterns and client protein preferences. YWHAG is particularly enriched in neuronal tissues, especially the hippocampus and cerebral cortex 4.
14-3-3 gamma modulates multiple signaling cascades:
Tyrosine Hydroxylase Regulation:
- Binds to and regulates tyrosine hydroxylase (TH)
- Controls dopamine biosynthesis
- Modulates catecholamine production
RAF-MEK-ERK Pathway:
- Regulates RAF kinase activity
- Modulates neuronal differentiation
- Controls cell survival signaling
PI3K-AKT Pathway:
- Interacts with AKT/PKB
- Modulates cell survival
- Important for neuronal viability
¶ Apoptosis and Cell Survival
BAD Sequestration:
- Phosphorylated BAD binds to 14-3-3 gamma
- Prevents BAD-mediated apoptosis
- Promotes neuronal survival
ASK1-JNK Pathway:
- Modulates stress-activated kinase cascades
- Regulates response to oxidative stress
- Controls neuronal apoptosis
Synaptic Transmission:
- Regulates neurotransmitter release
- Modulates synaptic vesicle cycling
- Controls presynaptic function
Synaptic Plasticity:
- Involved in LTP and LTD
- Regulates AMPA and NMDA receptors
- Important for learning and memory
Axonal Function:
- Modulates microtubule dynamics
- Regulates axonal transport
- Controls dendritic trafficking
14-3-3 gamma is significantly implicated in Alzheimer's disease:
Tau Pathology:
- Binds to hyperphosphorylated tau
- May regulate tau kinases (GSK3β, CDK5)
- Associates with neurofibrillary pathology
- Elevated in AD brain 5
Amyloid-β Interactions:
- Modulates Aβ toxicity
- May protect against or promote Aβ effects
- Alters APP processing pathways
Synaptic Dysfunction:
- Critical for synaptic protein regulation
- Altered in AD synapses
- Contributes to synaptic loss
Biomarker Potential:
- Detected in CSF of AD patients
- Proposed as progression marker
- Correlates with cognitive decline 6
α-Synuclein Interactions:
- 14-3-3 gamma binds α-synuclein
- Modulates aggregation propensity
- Found in Lewy bodies
- May influence LB formation 7
LRRK2 Regulation:
- Interacts with LRRK2 kinase
- May modulate PD-causing mutations
- Regulates LRRK2 signaling
Dopaminergic Neuron Protection:
- Protects dopaminergic neurons
- Modulates mitochondrial function
- Regulates oxidative stress responses
Huntington's Disease:
- 14-3-3 gamma altered in HD
- Modulates mutant huntingtin effects
- May influence aggregation
Amyotrophic Lateral Sclerosis:
- Interactions with ALS-related proteins
- TDP-43 pathology connection
- Motor neuron survival regulation
Prion Diseases:
- CSF 14-3-3 as diagnostic marker
- Marker for neuronal damage
- Included in CJD diagnostic criteria 8
Protein-Protein Interaction Modulation:
- Developing small molecules targeting 14-3-3 interactions
- Potential for neuroprotection
- Research actively ongoing
Enhancement Approaches:
- Stabilizing 14-3-3 function
- Promoting neuroprotective signaling
- Upregulating expression
- CSF/blood detection methods
- Disease progression markers
- Treatment response indicators
- Located on chromosome 7q11.23
- Encodes 247 amino acid protein
- Highly evolutionarily conserved
- Single nucleotide polymorphisms (SNPs) identified
- Some variants associated with disease risk
- Expression quantitative trait loci (eQTLs) in brain
¶ Detection and Analysis
- Western blot and ELISA
- Immunohistochemistry
- Mass spectrometry proteomics
- Co-immunoprecipitation
- Surface plasmon resonance
- Knockout mice (Ywhag -/-)
- Transgenic and mutant models
- Cell culture systems
- Drosophila melanogaster models
- 14-3-3 proteins: A highly conserved and versatile family. Nature, 1996.
- 14-3-3 proteins in disease. Nat Rev Cancer, 2006.
- Structure of 14-3-3 protein-protein interactions. EMBO J, 2000.
- 14-3-3 expression in brain. J Neurosci, 2001.
- 14-3-3 proteins in Alzheimer's disease brain. J Neuropathol Exp Neurol, 2002.
- Cerebrospinal fluid 14-3-3 in neurodegenerative disease. Neurology, 2005.
- α-Synuclein and 14-3-3 interactions. J Biol Chem, 2002.
- 14-3-3 proteins in prion disease diagnosis. Brain, 2002.